The Conversation (0)
TerrAscend Corp. ("TerrAscend" or the "Company") (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced that it will host a scheduled conference call to discuss the results for its fourth quarter and full year periods ended December 31, 2022 on Thursday, March 16, 2023 at 5:00 p.m. Eastern Time . The Company will report its financial results for the fourth quarter and full year 2022 the same day after market close.
| CONFERENCE CALL DETAILS | |
| | |
| Date: | Thursday, March 16, 2023 |
| Time: | 5:00 p.m. Eastern Time |
| RapidConnect URL: | |
| Webcast: | |
| Dial-in Number: | 1-888-664-6392 |
| Conference ID: | 95181103 |
| Replay: | 416-764-8677 or 1-888-390-0541 |
| | |
| | Available until 12:00 midnight Eastern Time Thursday, March 30, 2023 Replay Entry Code: 181103# |
The Canadian Securities Exchange ("CSE") has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
About TerrAscend
TerrAscend is a leading North American cannabis operator with vertically integrated operations in Pennsylvania , New Jersey , Michigan and California , licensed cultivation and processing operations in Maryland and licensed production in Canada . TerrAscend operates The Apothecarium and Gage dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities in its core markets. TerrAscend's cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use markets. The Company owns several synergistic businesses and brands, including Gage Cannabis, The Apothecarium, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. For more information, visit www.terrascend.com .
SOURCE TerrAscend
View original content to download multimedia: https://www.newswire.ca/en/releases/archive/February2023/28/c3007.html
